Anthony Kirck
Comptroller/Controller/Auditor bei OPTINOSE, INC.
Vermögen: 155 507 $ am 31.05.2024
Aktive Positionen von Anthony Kirck
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| OPTINOSE, INC. | Comptroller/Controller/Auditor | 01.11.2021 | - |
Karriereverlauf von Anthony Kirck
Ehemalige bekannte Positionen von Anthony Kirck
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| VERRICA PHARMACEUTICALS INC. | Comptroller/Controller/Auditor | 01.02.2020 | 01.11.2021 |
| STRONGBRIDGE BIOPHARMA | Corporate Officer/Principal | 01.06.2017 | 01.02.2020 |
Ausbildung von Anthony Kirck
| Albright College | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 4 |
| Irland | 2 |
Operativ
| Comptroller/Controller/Auditor | 2 |
| Undergraduate Degree | 1 |
| Corporate Officer/Principal | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| OPTINOSE, INC. | Health Technology |
| VERRICA PHARMACEUTICALS INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Strongbridge Biopharma Plc
 Strongbridge Biopharma Plc Pharmaceuticals: MajorHealth Technology Strongbridge Biopharma Plc operates as a commercial-stage biopharmaceutical company, which focuses on the development and commercialization of therapies for rare diseases. Its pipeline is comprised of Keveyis, Macrilen, Recorlev, and Veldoreotide. The company was founded in 1996 and is headquartered in Trevose, PA. | Health Technology |
- Börse
- Insiders
- Anthony Kirck
- Erfahrung
